ANITA ISHAQ-JUAREZ: Open Payments
NPI 1982102604 · AIEA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,073 in 68 payments from 13 companies in 2025. Trend: 2023 $761 · 2024 $1,362 · 2025 $1,073
Food & beverage: $1,067Education: $7
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 23 | $268 |
| Amgen Inc. | 14 | $210 |
| ABBVIE INC. | 11 | $155 |
| Regeneron Healthcare Solutions, Inc. | 6 | $139 |
| Janssen Biotech, Inc. | 3 | $73 |
| Incyte Corporation | 3 | $55 |
| PFIZER INC. | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Organon LLC | 1 | $25 |
| Biofrontera Inc. | 1 | $25 |
Products named: OTEZLA, ADBRY, SKYRIZI, ANZUPGO, TREMFYA, DUPIXENT, LIBTAYO, OPZELURA.
Industry payments across HI — which companies pay providers there.
